ActiTrexx

Health Care · Biotechnology
Lately:5 news stories in 90 daysFollow changes →

Facts

as of Nov 20, 2026

WELCOME TOACTITREXX At ActiTrexx we are developing novel therapies based on activated regulatory T cells (Treg). We aim to bring back tolerance to patients with dysfunctional immune system. Our goal is to tackle the root cause of autoimmune and autoinflammatory diseases, and.

Legal name
ActiTrexx GmbH
Founded
2002
Register numbers
VAT DE335671604 · HR HRB 49910

These are the key facts about ActiTrexx on Alion as of Nov 20, 2026. It was founded in 2002. The latest round is Venture - Series Unknown of $3.8M, announced in 2021.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Legal entity active
ActiTrexx GmbH
Not checked
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
SiteTypeOpen rolesHires most forEngineering
Mainz GermanyRegional office0
Source: office addresses in postings and company registers

Financials

Funding rounds, investors and revenue on record.

$3.8MTotal raised
Venture - Series UnknownLatest round
1Rounds and grants
Money by yearUSD, rounds and grants
2021$3.8M1 record
Largest rounds and grants
Sources: funding announcements, grant and company registers

Money

ActiTrexx has $3.8M paid in by investors, lenders and donors.

$3.8MPaid in
StagePaidSignedAnnouncedSourceFiledAnnouncedPress
Money in
Equity raised
Mar 2021 · Venture round
$3.8MPaid
Taxes
No public tax figures for this company or its entities.
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".

Milestones

Mar 2, 2021
2002
Founded
Each milestone is dated by its source: registers, filings, the press

Newsroom

Oct 72026
News · SWRAktuell.de
Das Biotech-Unternehmen ActiTrexx aus Mainz testet gerade eine weltweit einzigartige Zelltherapie zur Behandlung bei Blutkrebs.
Oct 72026
Blog
Ready in 24 Hours: ATreg Featured in Labiotech's GvHD Pipeline Review! The GvHD field is shifting from treating established disease toward preventing it by restoring immune toler…
Sep 282026
Blog
We are strengthening the IP foundation of our Treg platform! ActiTrexx GmbH is pleased to announce the publication of two new international patent applications in the field of in…
Sources: the outlets named on each headline, each story once